For Immediate Release
February 12, 2020
Bethesda, Md. – AABB (formerly known as the American Association of Blood Banks) is partnering with Mayo Clinic Laboratories to present “Transfuse 2020,” which will be held May 12-13 in Rochester, MN. This multidisciplinary conference will explore the evolution of patient blood management (PBM) and how it contributes to patient safety.
“AABB is proud to co-host Transfuse 2020 in collaboration with Mayo Clinic Laboratories,” said AABB CEO Debra BenAvram. “Patient blood management plays a fundamental role in patient safety. AABB’s support of this conference is in line with our new strategic plan, particularly the driver to ‘champion evidence-based clinical practices to improve patient and donor outcomes.’”
“Mayo Clinic Laboratories is proud to partner and collaborate with AABB on such an important and exciting conference,” said Andrew Higgins, Blood Program Manager at Mayo Clinic Laboratories. “Transfuse 2020 as a conference is designed to provide new and valuable information to attendees leveraging evidence based knowledge, experience, and technologies from experts and institutions throughout the medical community. Transfuse 2020 offers a platform for education as well as ample opportunity for networking, sharing ideas, insights and solutions which can impact patient care and improve patient blood management programs at any level of maturity.”
The two-day conference will feature didactic sessions, panel discussions, student poster abstracts and opportunities for participants to learn more about products and services in the exhibit hall. On the first day of Transfuse 2020, experts will focus on the history, impact and evolution of PBM; diagnostic management; how to develop anemic clinics; challenges with consent for blood transfusions; clinical decision support; the importance of data analytics and data management teams to help improve and streamline PBM programs; and novel systems for organizing cell therapies and regenerative medicine. Day two of the conference will kick off with breakout sessions, followed by an update on AABB’s PBM Standards and Accreditation. Pediatric transfusion; change management and PBM education in Australia will also be addressed during the second day of the conference, which will close with a panel discussion.
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.
# # #